Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0AP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,295
Award facts
- Contract value 100% obligated
- $34,295.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a contract ceiling value of $34,295.30. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the Defense Health Agency and other military healthcare systems through its comprehensive DLA contract vehicle, which enables the supply of a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs globally. NURTEC ODT (rimegepant) is a migraine treatment medication, and this delivery order represents a routine procurement within AmerisourceBergen's established pharmaceutical supply agreement with the federal government. The firm fixed-price structure and competitive award history demonstrate the company's established capability to meet federal medical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26FR0AP?
SPE2DR26FR0AP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FR0AP worth?
The government has obligated $34,295 on SPE2DR26FR0AP.
Is contract SPE2DR26FR0AP an order under another contract?
Yes. SPE2DR26FR0AP is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0AP competed?
The extent of competition for SPE2DR26FR0AP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award